🟢 Context Therapeutics is trading 5.8% up in after-hours trading with no clear company-specific catalyst identified

Context Therapeutics is trading at $0.24, up 5.79% after hours, with no clear company-specific catalyst identified.

• The latest listed company release was the September 9 CT-202 trial update.
• Broader sentiment was positive on October 21, with the Nasdaq Composite up 1.07%; this may have supported the move, but no direct link was established.
• The regular-session close was $0.23, down 5.09%. After-hours gains reverse part of that decline, following a steep slide from $0.28 on October 13.